According to LianBio's latest financial reports the company has S$0.34 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | S$0.40 B | -21.77% |
2021-12-31 | S$0.51 B | 53.98% |
2020-12-31 | S$0.33 B | 476.42% |
2019-12-31 | S$58.37 M |